You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Calquence

Showing 26 - 50 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in

Recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

COVID-19 Trial in Porto Alegre, Ribeirão Preto, Sao Paulo (Acalabrutinib)

Terminated
Has Results
  • COVID-19
  • Porto Alegre, Brazil
  • +3 more
Nov 16, 2021

Recurrent Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Nodal Marginal Zone Lymphoma Trial (Acalabrutinib,

Withdrawn
  • Recurrent Follicular Lymphoma
  • +8 more
  • (no location specified)
Jun 2, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2023

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Marginal Zone Lymphoma Trial in Austria, Italy, Switzerland (Tafasitamab, Acalabrutinib)

Recruiting
  • Marginal Zone Lymphoma
  • Wien, Austria
  • +9 more
Jul 13, 2022

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Aug 9, 2021

CLL Trial in Denmark, Netherlands, Sweden (Acalabrutinib, Venetoclax)

Recruiting
  • CLL
  • Copenhagen, Denmark
  • +5 more
Sep 17, 2021

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

Recruiting
  • Grade 1 Follicular Lymphoma
  • +7 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 7, 2021

Chronic Lymphoid Leukemia Trial in Austria, Germany (Acalabrutinib)

Recruiting
  • Chronic Lymphoid Leukemia
  • Acalabrutinib
  • Innsbruck, Austria
  • +19 more
Mar 21, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Denver, Colorado
  • +3 more
May 20, 2021

Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Bad Saarow, Germany
  • +29 more
May 4, 2022

Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)

Recruiting
  • Advanced Haematological Malignancies
  • Duarte, California
  • +38 more
Jul 22, 2022

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

DLBCL Trial in Houston (Acalabrutinib, Cyclophosphamide, Doxorubicin Hydrochloride)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Downey, California
  • +231 more
Jan 16, 2023